- Market Realist•2 days ago
Alexion Pharmaceuticals (ALXN) will announce its 3Q16 earnings on October 27, 2016. About 72.7% of the analysts covering the stock recommended a "buy."
- Zacks•2 days ago
The sector was once again under pressure following a drug pricing tweet by Senator Bernie Sanders regarding ARIAD's (ARIA) cancer treatment, Iclusig.
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Ask||373.98 x 100|
|Day's Range||368.30 - 373.89|
|52wk Range||329.09 - 592.59|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||57.92|
|Avg Vol (3m)||724,669|
|Dividend & Yield||N/A (N/A)|